Current Medical Research & Opinion

Evaluation of the cost-effectiveness of rifaximin-α for the management of patients with hepatic encephalopathy in the United Kingdom

http://dx.doi.org/10.1080/03007995.2018.1499506

Post author By Berni E R, Murphy D, Whitehouse J, Conway P, di Maggio P, Currie C J and Poole C D
Post date 13 August 2018

Berni E R, Murphy D, Whitehouse J, Conway P, di Maggio P, Currie C J, Poole C D. 13 Aug 2018

Berni E R

Murphy D

Whitehouse J

Conway P

di Maggio P

Currie C J

Poole C D

Transforming real-world data into transparent, reliable, and reliable real-world evidence

44 (0) 2920 782856

enquiries@humandatasciences.com

24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone® is a Trusted Research Environment (TRE)

Quick Links

Transforming real-world data into transparent, reliable, and replicable real-world evidence

44 (0) 2920 782856

instantRWE@humandatasciences.com

The Global Pharma Research Centre,
24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone^® is a Trusted Research Environment (TRE)

Web Design – Create Summit

Site by Create Summit